U.S.A. studies : Erythropoietin medicine increases the cancer patient thrombus risk nbsp

U.S.A. studies : Erythropoietin medicine increases the cancer patient thrombus risk nbsp
The research results that American researchers announce on the 10th reveal, taking erythropoietin types can increase the risk that the cancer patient suffers from the intravenous thrombus or pulmonary embolism to resist anaemia medicine notably.
The researchers of the Presbyterian hospital of New York and medical center of Columbia University are in U.S.A.>Pay, say, they are in 1991 Annual to 2002 In the period of correctly 5 Name 65 that there is many Wan Cancer of colon years old the above-mentioned, it is not that cellule lung cancer, breast cancer and filling the air big B cell lymphoma patient carried on research. Among them some patients take erythropoietin types to resist anaemia medicine while accepting chemotherapy. This kind of medicine can stimulate the bone marrow to make more red blood cells, got permission to be used in the cancer patient for the first time in 1991, in order to reduce the blood transfusion amount at the time of their chemotherapy.
Through discover patient to take medicine suffer from intravenous thrombus or risk of pulmonary embolism, higher than, take medicine patient notably for a long time researcher, and the bigger the taking medicine amount is, the higher the ill risk is, can reach as high as twice of the persons who have not taken medicine.
Lead Tang of this research hertz to say assortedly and gracefully, from 1991 to 2002, the consumption of the erythropoietin medicine increased by 10 times in U.S.A., nearly half accepts the cancer patient is using this kind of medicine in later period of chemotherapy. But study, show again, the medicine might the fraud is greater than the profit.
An item of research results that American Johson Johnson announced in 2006 reveals, taking the erythropoietin medicine can increase patient's mortality and suffer from the risk of the cardiovascular complication. American Food and Drug Administration has required in 2007 that increases black frame to warn on the label of this kind of medicine, and propose some patients of cancer reduce and use this kind of medicine. (Reporter Ren HaiJun )

|